Publications

• A 40-Year-Old With Prior Stem Cell Transplant for Chronic Myeloid Leukemia Presents With Dyspnea and Respiratory Failure.
  Chest Volume: 167 Page(s): e47 - e51
  02/01/2025 Authors: Naiditch H; Strollo H; Gipson V; Sica G; Joshi U; Ito S; Rossetti J; Hensley M
• Characteristics and anatomic location of PD-1+TCF1+ stem-like CD8 T cells in chronic viral infection and cancer.
  Proc Natl Acad Sci U S A Volume: 120 Page(s): e2221985120
  10/10/2023 Authors: Im SJ; Obeng RC; Nasti TH; McManus D; Kamphorst AO; Gunisetty S; Prokhnevska N; Carlisle JW; Yu K; Sica GL
• Early Detection and Staging of Lung Fibrosis Enabled by Collagen-Targeted MRI Protein Contrast Agent.
  Chem Biomed Imaging Volume: 1 Page(s): 268 - 285
  06/26/2023 Authors: Ibhagui OY; Li D; Han H; Peng G; Meister ML; Gui Z; Qiao J; Salarian M; Dong B; Yuan Y
• Darolutamide reverses osimertinib resistance in non-small cell lung cancer
  Volume: 83
  04/01/2023 Authors: Schmitz JC; Zhang G; Liu Z; Huang Y; Sica G; Sun S-Y; Owonikoko TK
• EGFR-phosphorylated GDH1 harmonizes with RSK2 to drive CREB activation and tumor metastasis in EGFR-activated lung cancer.
  Cell Rep Volume: 41 Page(s): 111827
  12/13/2022 Authors: Kang J; Chun J; Hwang JS; Pan C; Li J; Boese AC; Young I; Malin CM; Kang Y; Gibbons DL
• Mature tertiary lymphoid structures in lung adenocarcinoma are associated with better progression free survival
  Volume: 156 Page(s): S149 - S149
  10/01/2021 Authors: Obeng R; Parihar V; Alexis D; Behera M; Owonikoko T; Pillai R; Ramalingam S; Sica G; Ahmed R
• Mature Tertiary Lymphoid Structures in Lung Adenocarcinoma Are Associated With Better Progression Free Survival
  Volume: 16 Page(s): S912 - S913
  10/01/2021 Authors: Obeng R; Parihar V; Alexis D; Sica G
• p40 and p63 Immunohistochemistry in the Diagnostic Consideration of NUT Carcinoma in the Lung
  Volume: 16 Page(s): S1065 - S1066
  10/01/2021 Authors: Roe C; Hanley K; Schneider F; Owonikoko T; Sica G
• YAP1 Expression in SCLC Defines a Distinct Subtype With T-cell-Inflamed Phenotype.
  J Thorac Oncol Volume: 16 Page(s): 464 - 476
  03/01/2021 Authors: Owonikoko TK; Dwivedi B; Chen Z; Zhang C; Barwick B; Ernani V; Zhang G; Gilbert-Ross M; Carlisle J; Khuri FR
• Leflunomide Suppresses the Growth of LKB1-Inactivated Tumors in the Immune-Competent Host and Attenuates Distant Cancer Metastasis.
  Mol Cancer Ther Volume: 20 Page(s): 274 - 283
  02/01/2021 Authors: Jin R; Liu B; Liu X; Fan Y; Peng W; Huang C; Marcus A; Sica G; Gilbert-Ross M; Liu Y
• Epigenetic modulation of FBW7/Mcl-1 pathway for lung cancer therapy.
  Cancer Biol Ther Volume: 22 Page(s): 55 - 65
  01/02/2021 Authors: Kim MJ; Chen G; Sica GL; Deng X
• Discovery of Small Molecule Bak Activator for Lung Cancer Therapy.
  Theranostics Volume: 11 Page(s): 8500 - 8516
  01/01/2021 Authors: Park D; Anisuzzaman ASM; Magis AT; Chen G; Xie M; Zhang G; Behera M; Sica GL; Ramalingam SS; Owonikoko TK
• Durvalumab and tremelimumab with or without stereotactic body radiation therapy in relapsed small cell lung cancer: a randomized phase II study.
  J Immunother Cancer Volume: 8
  12/01/2020 Authors: Pakkala S; Higgins K; Chen Z; Sica G; Steuer C; Zhang C; Zhang G; Wang S; Hossain MS; Nazha B
• Incidental Detection of Lung Adenocarcinoma Presenting as an Anterior Mediastinal Mass on 18F-Fluciclovine PET/CT in a Patient With Primary Prostate Cancer.
  Clin Nucl Med Volume: 45 Page(s): e525 - e527
  12/01/2020 Authors: Abiodun-Ojo OA; Akintayo AA; Sica GL; Alemozaffar M; Schuster DM
• Bcl2-induced DNA replication stress promotes lung carcinogenesis in response to space radiation.
  Carcinogenesis Volume: 41 Page(s): 1565 - 1575
  11/13/2020 Authors: Xie M; Park D; Sica GL; Deng X
• Round Robin Evaluation of MET Protein Expression in Lung Adenocarcinomas Improves Interobserver Concordance.
  Appl Immunohistochem Mol Morphol Volume: 28 Page(s): 669 - 677
  10/01/2020 Authors: Boyle TA; Khalil FK; Mino-Kenudson M; Sica GL; Moreira AL; Sholl LM; Knight MZ; Zhang L; Saller J; Varella-Garcia M
• LAM MIMICS: AIRWAY-CENTERED CYSTIC LUNG DISEASE
  Volume: 158 Page(s): 1056A - 1056A
  10/01/2020 Authors: Gripaldo R; Berkowitz E; Schneider F; Sica G; Veeraraghavan S
• Granulomatous lung disease: clinical aspects.
  Expert Rev Respir Med Volume: 14 Page(s): 1045 - 1063
  10/01/2020 Authors: Chopra A; Avadhani V; Tiwari A; Riemer EC; Sica G; Judson MA
• A Phase I Study of Safety, Pharmacokinetics, and Pharmacodynamics of Concurrent Everolimus and Buparlisib Treatment in Advanced Solid Tumors.
  Clin Cancer Res Volume: 26 Page(s): 2497 - 2505
  06/01/2020 Authors: Owonikoko TK; Harvey RD; Carthon B; Chen Z; Lewis C; Collins H; Zhang C; Lawson DH; Alese OB; Bilen MA
• Correction to: Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
  Mol Cancer Volume: 19 Page(s): 93
  05/20/2020 Authors: Xu K; Park D; Magis AT; Zhang J; Zhou W; Sica GL; Ramalingam SS; Curran WJ; Deng X
• Association Between PD-L1 Expression and c-Met Alterations in Non-Small Cell Lung Carcinoma
  Volume: 100 Page(s): 1821 - 1821
  03/01/2020 Authors: Tenney T; Sica G; Saxe D; Owonikoko T; Ramalingam S; Zhang L
• Association Between PD-L1 Expression and c-Met Alterations in Non-Small Cell Lung Carcinoma
  Volume: 33 Page(s): 1821 - 1821
  03/01/2020 Authors: Tenney T; Sica G; Saxe D; Owonikoko T; Ramalingam S; Zhang L
• Improved Interobserver Agreement in Keratin Immunohistochemistry-Assisted Diagnosis of Peritoneal Membrane Invasion by Colorectal Adenocarcinoma
  Volume: 100 Page(s): 632 - 633
  03/01/2020 Authors: Chen J-H; Deshpande V; Goyal R; Guinee D; Sica G; Thomassen L; Westerhoff M
• Improved Interobserver Agreement in Keratin Immunohistochemistry-Assisted Diagnosis of Peritoneal Membrane Invasion by Colorectal Adenocarcinoma
  Volume: 33 Page(s): 632 - 633
  03/01/2020 Authors: Chen J-H; Deshpande V; Goyal R; Guinee D; Sica G; Thomassen L; Westerhoff M
• Mcl-1 Interacts with Akt to Promote Lung Cancer Progression.
  Cancer Res Volume: 79 Page(s): 6126 - 6138
  12/15/2019 Authors: Chen G; Park D; Magis AT; Behera M; Ramalingam SS; Owonikoko TK; Sica GL; Ye K; Zhang C; Chen Z
• The Presence of Secondary Follicles in Early Stage Lung Adenocarcinoma Reflects Disease Burden
  Volume: 14 Page(s): S1146 - S1146
  11/01/2019 Authors: Obeng R; Behera M; Owonikoko T; Pillai R; Ahmed R; Ramalingam S; Sica G
• Feasibility of Hyperfunctioning Parathyroid Gland Localization Using [18F]fluciclovine PET/CT.
  Mol Imaging Biol Volume: 21 Page(s): 818 - 824
  10/01/2019 Authors: Akintayo AA; Abiodun-Ojo OA; Weber C; Sharma J; Cohen C; Sica G; Halkar R; Goodman MM; Schuster DM
• The Biospecimen Preanalytical Variables Program: A Multiassay Comparison of Effects of Delay to Fixation and Fixation Duration on Nucleic Acid Quality.
  Arch Pathol Lab Med Volume: 143 Page(s): 1106 - 1118
  09/01/2019 Authors: Carithers LJ; Agarwal R; Guan P; Odeh H; Sachs MC; Engel KB; Greytak SR; Barcus M; Soria C; Lih C-JJ
• Isolation of circulating tumors cells from genetically engineered mouse models of lung adenocarcinoma
  Volume: 79
  07/01/2019 Authors: Burton LJ; Koo J; Tucker-Burden C; Zhou W; Gilbert-Ross M; Huang C; Sica G; Marcus A
• Characteristics and Outcomes of Patients With Metastatic KRAS-Mutant Lung Adenocarcinomas: The Lung Cancer Mutation Consortium Experience.
  J Thorac Oncol Volume: 14 Page(s): 876 - 889
  05/01/2019 Authors: El Osta B; Behera M; Kim S; Berry LD; Sica G; Pillai RN; Owonikoko TK; Kris MG; Johnson BE; Kwiatkowski DJ
• Small Molecule KRAS Agonist for Mutant KRAS Cancer Therapy.
  Mol Cancer Volume: 18 Page(s): 85
  04/10/2019 Authors: Xu K; Park D; Magis AT; Zhang J; Zhou W; Sica GL; Ramalingam SS; Curran WJ; Deng X
• A peripheral cause of asthma: Peripheral T-cell lymphoma.
  Ann Allergy Asthma Immunol Volume: 122 Page(s): 420 - 422
  04/01/2019 Authors: Ramonell RP; Kuruvilla M; Sica G; Bag R; Eun-Hyung Lee F
• Protein Mass Spectrometry and Ultrastructural Examination of Pulmonary Light Chain Deposition Disease
  Volume: 99
  03/01/2019 Authors: Xiong M-J; Kurtin P; Farris A; Sica G; Schneider F
• Protein Mass Spectrometry and Ultrastructural Examination of Pulmonary Light Chain Deposition Disease
  Volume: 32
  03/01/2019 Authors: Xiong M-J; Kurtin P; Farris A; Sica G; Schneider F
• Randomized Phase II Trial of Cisplatin and Etoposide in Combination With Veliparib or Placebo for Extensive-Stage Small-Cell Lung Cancer: ECOG-ACRIN 2511 Study.
  J Clin Oncol Volume: 37 Page(s): 222 - 229
  01/20/2019 Authors: Owonikoko TK; Dahlberg SE; Sica GL; Wagner LI; Wade JL; Srkalovic G; Lash BW; Leach JW; Leal TB; Aggarwal C
• A Pan-Cancer Analysis Reveals High-Frequency Genetic Alterations in Mediators of Signaling by the TGF- Superfamily.
  Cell Syst Volume: 7 Page(s): 422 - 437.e7
  10/24/2018 Authors: Korkut A; Zaidi S; Kanchi RS; Rao S; Gough NR; Schultz A; Li X; Lorenzi PL; Berger AC; Robertson G
• SLFN11 Expression and Efficacy of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study
  Volume: 13 Page(s): S972 - S972
  10/01/2018 Authors: Owonikoko T; Dahlberg S; Sica G; Poirier J; Byers L; Rudin C; Wistuba I; Ramalingam S
• Targeted sequencing and intracranial outcomes of patients with lung adenocarcinoma brain metastases treated with radiotherapy.
  Cancer Volume: 124 Page(s): 3586 - 3595
  09/01/2018 Authors: Press RH; Zhang C; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Kahn S; Ramalingam SS
• Comprehensive Analysis of Alternative Splicing Across Tumors from 8,705 Patients.
  Cancer Cell Volume: 34 Page(s): 211 - 224.e6
  08/13/2018 Authors: Kahles A; Lehmann K-V; Toussaint NC; Hser M; Stark SG; Sachsenberg T; Stegle O; Kohlbacher O; Sander C; Cancer Genome Atlas Research Network
• Targeting Mcl-1 enhances DNA replication stress sensitivity for cancer therapy
  Volume: 78
  07/01/2018 Authors: Chen G; Magis A; Xu K; Park D; Yu D; Owonikoko T; Sica G; Satola S; Ramalingam S; Curran W
• A Comprehensive Pan-Cancer Molecular Study of Gynecologic and Breast Cancers.
  Cancer Cell Volume: 33 Page(s): 690 - 705.e9
  04/09/2018 Authors: Berger AC; Korkut A; Kanchi RS; Hegde AM; Lenoir W; Liu W; Liu Y; Fan H; Shen H; Ravikumar V
• Comparative Molecular Analysis of Gastrointestinal Adenocarcinomas.
  Cancer Cell Volume: 33 Page(s): 721 - 735.e8
  04/09/2018 Authors: Liu Y; Sethi NS; Hinoue T; Schneider BG; Cherniack AD; Sanchez-Vega F; Seoane JA; Farshidfar F; Bowlby R; Islam M
• Genomic and Functional Approaches to Understanding Cancer Aneuploidy.
  Cancer Cell Volume: 33 Page(s): 676 - 689.e3
  04/09/2018 Authors: Taylor AM; Shih J; Ha G; Gao GF; Zhang X; Berger AC; Schumacher SE; Wang C; Hu H; Liu J
• Comprehensive Characterization of Cancer Driver Genes and Mutations.
  Cell Volume: 173 Page(s): 371 - 385.e18
  04/05/2018 Authors: Bailey MH; Tokheim C; Porta-Pardo E; Sengupta S; Bertrand D; Weerasinghe A; Colaprico A; Wendl MC; Kim J; Reardon B
• Oncogenic Signaling Pathways in The Cancer Genome Atlas.
  Cell Volume: 173 Page(s): 321 - 337.e10
  04/05/2018 Authors: Sanchez-Vega F; Mina M; Armenia J; Chatila WK; Luna A; La KC; Dimitriadoy S; Liu DL; Kantheti HS; Saghafinia S
• Pathogenic Germline Variants in 10,389 Adult Cancers.
  Cell Volume: 173 Page(s): 355 - 370.e14
  04/05/2018 Authors: Huang K-L; Mashl RJ; Wu Y; Ritter DI; Wang J; Oh C; Paczkowska M; Reynolds S; Wyczalkowski MA; Oak N
• Cell-of-Origin Patterns Dominate the Molecular Classification of 10,000 Tumors from 33 Types of Cancer.
  Cell Volume: 173 Page(s): 291 - 304.e6
  04/05/2018 Authors: Hoadley KA; Yau C; Hinoue T; Wolf DM; Lazar AJ; Drill E; Shen R; Taylor AM; Cherniack AD; Thorsson V
• Genomic and Molecular Landscape of DNA Damage Repair Deficiency across The Cancer Genome Atlas.
  Cell Rep Volume: 23 Page(s): 239 - 254.e6
  04/03/2018 Authors: Knijnenburg TA; Wang L; Zimmermann MT; Chambwe N; Gao GF; Cherniack AD; Fan H; Shen H; Way GP; Greene CS
• Machine Learning Detects Pan-cancer Ras Pathway Activation in The Cancer Genome Atlas.
  Cell Rep Volume: 23 Page(s): 172 - 180.e3
  04/03/2018 Authors: Way GP; Sanchez-Vega F; La K; Armenia J; Chatila WK; Luna A; Sander C; Cherniack AD; Mina M; Ciriello G
• Genomic, Pathway Network, and Immunologic Features Distinguishing Squamous Carcinomas.
  Cell Rep Volume: 23 Page(s): 194 - 212.e6
  04/03/2018 Authors: Campbell JD; Yau C; Bowlby R; Liu Y; Brennan K; Fan H; Taylor AM; Wang C; Walter V; Akbani R
• The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma.
  Cell Rep Volume: 23 Page(s): 313 - 326.e5
  04/03/2018 Authors: Ricketts CJ; De Cubas AA; Fan H; Smith CC; Lang M; Reznik E; Bowlby R; Gibb EA; Akbani R; Beroukhim R
• Orthopedia homeobox is preferentially expressed in typical carcinoids of the lung.
  Volume: 126 Page(s): 236 - 242
  04/01/2018 Authors: Hanley KZ; Dureau ZJ; Cohen C; Shin DM; Owonikoko TK; Sica GL
• Scalable Open Science Approach for Mutation Calling of Tumor Exomes Using Multiple Genomic Pipelines.
  Cell Syst Volume: 6 Page(s): 271 - 281.e7
  03/28/2018 Authors: Ellrott K; Bailey MH; Saksena G; Covington KR; Kandoth C; Stewart C; Hess J; Ma S; Chiotti KE; McLellan M
• Pan-cancer Alterations of the MYC Oncogene and Its Proximal Network across the Cancer Genome Atlas.
  Cell Syst Volume: 6 Page(s): 282 - 300.e2
  03/28/2018 Authors: Schaub FX; Dhankani V; Berger AC; Trivedi M; Richardson AB; Shaw R; Zhao W; Zhang X; Ventura A; Liu Y
• The Integrated Genomic Landscape of Thymic Epithelial Tumors.
  Cancer Cell Volume: 33 Page(s): 244 - 258.e10
  02/12/2018 Authors: Radovich M; Pickering CR; Felau I; Ha G; Zhang H; Jo H; Hoadley KA; Anur P; Zhang J; McLellan M
• Vimentin Is Required for Lung Adenocarcinoma Metastasis via Heterotypic Tumor Cell-Cancer-Associated Fibroblast Interactions during Collective Invasion.
  Clin Cancer Res Volume: 24 Page(s): 420 - 432
  01/15/2018 Authors: Richardson AM; Havel LS; Koyen AE; Konen JM; Shupe J; Wiles WG; Martin WD; Grossniklaus HE; Sica G; Gilbert-Ross M
• Targeting Mcl-1 enhances DNA replication stress sensitivity to cancer therapy.
  J Clin Invest Volume: 128 Page(s): 500 - 516
  01/02/2018 Authors: Chen G; Magis AT; Xu K; Park D; Yu DS; Owonikoko TK; Sica GL; Satola SW; Ramalingam SS; Curran WJ
• Prognostic biomarkers in patients with human immunodeficiency virus-positive disease with head and neck squamous cell carcinoma.
  Head Neck Volume: 39 Page(s): 2433 - 2443
  12/01/2017 Authors: Zhang H; Kim S; Chen Z; Nannapaneni S; Chen AY; Moore CE; Sica G; Mosunjac M; Nguyen MLT; D'Souza G
• Comprehensive and Integrated Genomic Characterization of Adult Soft Tissue Sarcomas.
  Cell Volume: 171 Page(s): 950 - 965.e28
  11/02/2017 Authors: Cancer Genome Atlas Research Network. Electronic address: elizabeth.demicco@sinaihealthsystem.ca; Cancer Genome Atlas Research Network
• Exploratory Analysis for Predictors of Benefit of PARP Inhibitor Therapy in Extensive Stage Small Cell Lung Cancer: ECOG-ACRIN 2511 Study
  Volume: 12 Page(s): S1766 - S1767
  11/01/2017 Authors: Owonikoko T; Dahlberg S; Poirier J; Sica G; Rudin C; Ramalingam S
• Head to Head Comparison of Archer VariantPlex/FusionPlex Solid Tumor and the Illumina TruSight Tumor 170 Assays
  Volume: 19 Page(s): 1028 - 1028
  11/01/2017 Authors: Rouhi O; Schneider T; Jones H; Hauenstein J; Tillson H; Cooper B; Lutz B; Tucker K; Mellott J; Kuraishy A
• KRAS Mutant Non-small Cell Lung Cancer is Associated With Increased Risk of Salvage Whole Brain Radiation after Stereotactic Radiosurgery for Brain Metastases
  Volume: 99 Page(s): E100 - E101
  10/01/2017 Authors: Press RH; Zhang X; Cassidy RJ; Ferris MJ; Zhong J; Steuer C; Pillai R; Owonikoko TK; Ramalingam S; Patel PR
• Next Generation Sequencing and Clinical Outcomes of Lung Adenocarcinomas Treated With Stereotactic Body Radiation Therapy
  Volume: 99 Page(s): S241 - S241
  10/01/2017 Authors: Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer C; Pillai R
• Next-generation sequencing and clinical outcomes of patients with lung adenocarcinoma treated with stereotactic body radiotherapy.
  Cancer Volume: 123 Page(s): 3681 - 3690
  10/01/2017 Authors: Cassidy RJ; Zhang X; Patel PR; Shelton JW; Escott CE; Sica GL; Rossi MR; Hill CE; Steuer CE; Pillai RN
• Assays for PD-L1 Expression: Do All Roads Lead to Rome?
  JAMA Oncol Volume: 3 Page(s): 1058 - 1059
  08/01/2017 Authors: Sica GL; Ramalingam SS
• Modulation of Bax and mTOR for cancer therapeutics
  Volume: 77
  07/01/2017 Authors: Li R; Ding C; Zhang J; Xie M; Park D; Ding Y; Chen G; Zhang G; Gilbert-Ross M; Zhou W
• Modulation of Bax and mTOR for Cancer Therapeutics.
  Cancer Res Volume: 77 Page(s): 3001 - 3012
  06/01/2017 Authors: Li R; Ding C; Zhang J; Xie M; Park D; Ding Y; Chen G; Zhang G; Gilbert-Ross M; Zhou W
• Early proliferation of PD-1+CD8 T cells in peripheral blood as predictive of response to PD-1 inhibition for patients with advanced NSCLC
  Volume: 35
  05/20/2017 Authors: Pillai RN; Kamphorst A; Yang S; Owonikoko TK; Sica G; Nasti T; Akondy R; Wieland A; Wu H; Patel N
• Presence of genetic aberrations in patients with brain metastases from non-small cell lung cancer (NSCLC) and clinical outcomes
  Volume: 35
  05/20/2017 Authors: Press RH; Zhang X; Cassidy RJ; Ferris MJ; Zhong J; Steuer CE; Pillai RN; Owonikoko TK; Ramalingam SS; Patel PR
• Proliferation of PD-1+ CD8 T cells in peripheral blood after PD-1-targeted therapy in lung cancer patients.
  Proc Natl Acad Sci U S A Volume: 114 Page(s): 4993 - 4998
  05/09/2017 Authors: Kamphorst AO; Pillai RN; Yang S; Nasti TH; Akondy RS; Wieland A; Sica GL; Yu K; Koenig L; Patel NT
• Rescue of exhausted CD8 T cells by PD-1-targeted therapies is CD28-dependent.
  Volume: 355 Page(s): 1423 - 1427
  03/31/2017 Authors: Kamphorst AO; Wieland A; Nasti T; Yang S; Zhang R; Barber DL; Konieczny BT; Daugherty CZ; Koenig L; Yu K
• Targeting adhesion signaling in KRAS, LKB1 mutant lung adenocarcinoma.
  JCI Insight Volume: 2 Page(s): e90487
  03/09/2017 Authors: Gilbert-Ross M; Konen J; Koo J; Shupe J; Robinson BS; Wiles WG; Huang C; Martin WD; Behera M; Smith GH
• Neuroendocrine Neoplasms of the Gallbladder. An Immunohistochemical and Clinicopathologic Analysis of 29 Cases
  Volume: 97 Page(s): 196A - 196A
  02/01/2017 Authors: Reid MD; Roa JC; Memis B; Muraki T; Araya JC; Villaseca M; Losada H; Sarmiento JM; Sica G; Adsay V
• PD-L1 Expression in DNA Mismatch-Repair-Deficient and Medullary-Type Ampullary Carcinomas
  Volume: 97 Page(s): 208A - 208A
  02/01/2017 Authors: Xue Y; Sica G; Muraki T; Memis B; Balci S; Cohen C; Quigley B; Krasinskas A; Reid MD; Adsay V
• NKX3.1 Is a Marker of Salivary Duct Carcinoma (SDC)
  Volume: 97 Page(s): 333A - 333A
  02/01/2017 Authors: Sica G; Cohen C; Griffith CC
• PD-L1 Expression in DNA Mismatch-Repair-Deficient and Medullary-Type Ampullary Carcinomas
  Volume: 30 Page(s): 208A - 208A
  02/01/2017 Authors: Xue Y; Sica G; Muraki T; Memis B; Balci S; Cohen C; Quigley B; Krasinskas A; Reid MD; Adsay V
• NKX3.1 Is a Marker of Salivary Duct Carcinoma (SDC)
  Volume: 30 Page(s): 333A - 333A
  02/01/2017 Authors: Sica G; Cohen C; Griffith CC
• Orthopedia Homeobox (OTP) Is Preferentially Expressed in Typical Carcinoids of the Lung
  Volume: 30 Page(s): 94A - 94A
  02/01/2017 Authors: Dureau Z; Sica G; Cohen C; Owonikoko TK; Hanley KZ
• Integrated genomic characterization of oesophageal carcinoma.
  Nature Volume: 541 Page(s): 169 - 175
  01/12/2017 Authors: Cancer Genome Atlas Research Network; Analysis Working Group: Asan University; BC Cancer Agency; Brigham and Womens Hospital; Broad Institute; Brown University; Case Western Reserve University; Dana-Farber Cancer Institute; Duke University; Greater Poland Cancer Centre
• Cardiac allograft rejection as a complication of PD-1 checkpoint blockade for cancer immunotherapy: a case report.
  Cancer Immunol Immunother Volume: 66 Page(s): 45 - 50
  01/01/2017 Authors: Owonikoko TK; Kumar M; Yang S; Kamphorst AO; Pillai RN; Akondy R; Nautiyal V; Chatwal MS; Book WM; Sahu A
• Non-neutralizing antibodies induced by seasonal influenza vaccine prevent, not exacerbate A(H1N1)pdm09 disease.
  Sci Rep Volume: 6 Page(s): 37341
  11/16/2016 Authors: Kim JH; Reber AJ; Kumar A; Ramos P; Sica G; Music N; Guo Z; Mishina M; Stevens J; York IA
• Construction and Validation of a Multi-Institutional Tissue Microarray of Invasive Ductal Carcinoma From Racially and Ethnically Diverse Populations.
  Cancer Control Volume: 23 Page(s): 383 - 389
  10/01/2016 Authors: Seijo E; Lima D; Iriabho E; Almeida J; Monico J; Echeverri M; Gutierrez S; Flores I; Lee J-H; Fisher K
• Lung Adenocarcinoma Staging Using the 2011 IASLC/ATS/ERS Classification: A Pooled Analysis of Adenocarcinoma In Situ and Minimally Invasive Adenocarcinoma.
  Volume: 17 Page(s): e57 - e64
  09/01/2016 Authors: Behera M; Owonikoko TK; Gal AA; Steuer CE; Kim S; Pillai RN; Khuri FR; Ramalingam SS; Sica GL
• Beyond EMT: Vimentin function in lung cancer metastasis
  Volume: 76
  08/01/2016 Authors: Salgueiro AM; Gilbert-Ross M; Havel LS; Shupe J; Koyen AE; Grossniklaus HE; Sica G; Marcus AI
• Developing a personalized anti-metastatic therapy to treat KRAS, LKB1-mutant lung adenocarcinoma
  Volume: 76
  07/01/2016 Authors: Gilbert-Ross M; Konen J; Koo J; Shupe J; Sica GL; Chen Z; Robinson BS; Behera M; Rossi MR; Smith GH
• An evaluation of NGS to identify gene fusions using RNA from FFPE solid tumor samples
  Volume: 76
  07/01/2016 Authors: Parks JT; Byron L; Crain B; June S; Chen Z; Du T; Sica GL; Owonikoko TK; Neill SG; Newman S
• Patient-derived xenografts faithfully replicated clinical outcome in a phase II co-clinical trial of arsenic trioxide in relapsed small cell lung cancer.
  J Transl Med Volume: 14 Page(s): 111
  05/03/2016 Authors: Owonikoko TK; Zhang G; Kim HS; Stinson RM; Bechara R; Zhang C; Chen Z; Saba NF; Pakkala S; Pillai R
• EVALUATION OF TUMOR PD-1 EXPRESSION AS A PROGNOSTIC BIOMARKER IN PATIENTS WITH LOCALIZED CLEAR CELL RENAL CELL CARCINOMA
  Volume: 195 Page(s): E1161 - E1162
  04/01/2016 Authors: Kim K; Sekar R; DiMarco M; Petit D; Osunkoya A; Sica G; Kissick H; Pollack B; Master V
• An early treatment window to target FAK-dependent collective invasion in Lkb1-mutant lung adenocarcinoma
  Volume: 76
  04/01/2016 Authors: Gilbert-Ross M; Konen J; Shupe J; Koo J; Sica GL; Ramalingam SS; Fu H; Khuri FR; Zhou W; Marcus AI
• Clinical Validation and Implementation of a Targeted Next-Generation Sequencing Assay to Detect Somatic Variants in Non-Small Cell Lung, Melanoma, and Gastrointestinal Malignancies.
  J Mol Diagn Volume: 18 Page(s): 299 - 315
  03/01/2016 Authors: Fisher KE; Zhang L; Wang J; Smith GH; Newman S; Schneider TM; Pillai RN; Kudchadkar RR; Owonikoko TK; Ramalingam SS
• Role of race in oncogenic driver prevalence and outcomes in lung adenocarcinoma: Results from the Lung Cancer Mutation Consortium.
  Cancer Volume: 122 Page(s): 766 - 772
  03/01/2016 Authors: Steuer CE; Behera M; Berry L; Kim S; Rossi M; Sica G; Owonikoko TK; Johnson BE; Kris MG; Bunn PA
• Phosphorylated Bcl-2 and Mcl-1 as prognostic markers in small cell lung cancer.
  Oncotarget
  02/18/2016 Authors: Chowdry RP; Sica GL; Kim S; Chen Z; Goodman A; Alexis D; Deng X; Owonikoko TK
• PD-1 expression and its impact on survival in localized clear cell renal cell carcinoma
  Volume: 34
  01/10/2016 Authors: Sekar RR; DiMarco MA; Patil D; Osunkoya AO; Pollack BP; Sica G; Master VA
• Beyond EMT: vimentin function in lung cancer metastasis.
  Volume: 27
  01/01/2016 Authors: Salgueiro AM; Havel LS; Shupe J; Koyen AE; Grossniklaus HE; Sica G; Gilbert-Ross M; Marcus AI
• Preclinical In Vitro, In Vivo, and Pharmacokinetic Evaluations of FLLL12 for the Prevention and Treatment of Head and Neck Cancers.
  Cancer Prev Res (Phila) Volume: 9 Page(s): 63 - 73
  01/01/2016 Authors: Anisuzzaman ASM; Haque A; Rahman MA; Wang D; Fuchs JR; Hurwitz S; Liu Y; Sica G; Khuri FR; Chen ZG
• Diffuse Idiopathic Pulmonary Neuroendocrine Cell Hyperplasia (DIPNECH): Descriptive Analysis and Overall Survival
  JOURNAL OF THORACIC ONCOLOGY Volume: 10 Page(s): S355 - S355
  09/01/2015 Authors: Kumar M; Zhang C; Chen Z; Nelson M; Ernani V; Staton G; Veeraraghavan S; Gal A; Sica G; Owonikoko TK
• Characterization of MET Gene and MET Protein Expression in Lung Cancer
  JOURNAL OF THORACIC ONCOLOGY Volume: 10 Page(s): S308 - S308
  09/01/2015 Authors: Boyle TA; Lu X; Berry L; Ellison KE; Kowalewski AA; Rivard CJ; Khalil F; Mino-Kenudson M; Moreira A; Sholl L
• Lung Cancer Mutation Consortium Pathologist Panel Evaluation of MET Protein
  JOURNAL OF THORACIC ONCOLOGY Volume: 10 Page(s): S248 - S248
  09/01/2015 Authors: Boyle TA; Khalil F; Mino-Kenudson M; Moreira A; Sholl L; Sica G; Knight MZ; Kowalewski AA; Ellison K; Rivard CJ
• Metabolic Rewiring by Oncogenic BRAF V600E Links Ketogenesis Pathway to BRAF-MEK1 Signaling.
  Mol Cell Volume: 59 Page(s): 345 - 358
  08/06/2015 Authors: Kang H-B; Fan J; Lin R; Elf S; Ji Q; Zhao L; Jin L; Seo JH; Shan C; Arbiser JL
• Biomarker evaluation for PD-1 targeted therapies in non-small cell lung cancer (NSCLC) patients
  Volume: 75
  08/01/2015 Authors: Kamphorst AO; Pillai RN; Yang S; Akondy R; Koenig L; Yu K; McCausland M; Sica G; Khuri FR; Owonikoko TK
• A phase I pharmacokinetic and pharmacodynamic evaluation of the combination of everolimus and buparlisib for concurrent mTOR and PI3K pathway blockade in patients with advanced solid tumors
  Volume: 75
  08/01/2015 Authors: Owonikoko TK; Harvey RD; Lewis C; Chen Z; Kauh JS; Renfroe M; Deovic R; Sica GL; Carthon BC; Harris WB
• Development of Bcl2 BH4 antagonist for cancer therapy
  Volume: 75
  08/01/2015 Authors: Han B; Park D; Li R; Xie M; Owonikoko T; Sica G; Ding C; Zhou J; Magis A; Ramalingam S
• A Bystander Effect of Lung Cancer Chemotherapy on Chronic Echinococcal Disease.
  World J Oncol Volume: 6 Page(s): 416 - 420
  08/01/2015 Authors: Bangaru SD; Kozarsky PE; Lee DJ; Sica GL; Owonikoko TK
• Genomic Classification of Cutaneous Melanoma.
  Cell Volume: 161 Page(s): 1681 - 1696
  06/18/2015 Authors: Cancer Genome Atlas Network
• Small-Molecule Bcl2 BH4 Antagonist for Lung Cancer Therapy.
  Cancer Cell Volume: 27 Page(s): 852 - 863
  06/08/2015 Authors: Han B; Park D; Li R; Xie M; Owonikoko TK; Zhang G; Sica GL; Ding C; Zhou J; Magis AT
• PD-L1, PD-1, and CTLA-4 as prognostic biomarkers in resected non-small cell lung cancer.
  Volume: 33
  05/20/2015 Authors: Owonikoko TK; Kowalski J; Kim S; Dwivedi B; Chen Z; Behera M; Mayfield W; Hermann RC; Chen L; Khuri FR
• Comparative genomics of pulmonary and extrapulmonary small cell carcinoma.
  Volume: 33
  05/20/2015 Authors: Sica G; Hanley K; Newman S; Mosunjac M; Martinez A; Han E; Zhang G; Ramalingam SS; Khuri FR; Rossi MR
• A Translational, Pharmacodynamic, and Pharmacokinetic Phase IB Clinical Study of Everolimus in Resectable Non-Small Cell Lung Cancer.
  Clin Cancer Res Volume: 21 Page(s): 1859 - 1868
  04/15/2015 Authors: Owonikoko TK; Ramalingam SS; Miller DL; Force SD; Sica GL; Mendel J; Chen Z; Rogatko A; Tighiouart M; Harvey RD
• Anaplastic lymphoma kinase (ALK) gene alteration in signet ring cell carcinoma of the gastrointestinal tract.
  Ther Adv Med Oncol Volume: 7 Page(s): 56 - 62
  03/01/2015 Authors: Alese OB; El-Rayes BF; Sica G; Zhang G; Alexis D; La Rosa FG; Varella-Garcia M; Chen Z; Rossi MR; Adsay NV
• Peripheral T Cell Lymphoma Masquerading As Asthma And Eosinophilia
  Volume: 191
  01/01/2015 Authors: Egea E; Sica G; Gaddh M; Bag R; Lee F-H
• Poly (ADP) ribose polymerase enzyme inhibitor, veliparib, potentiates chemotherapy and radiation in vitro and in vivo in small cell lung cancer.
  Cancer Med Volume: 3 Page(s): 1579 - 1594
  12/01/2014 Authors: Owonikoko TK; Zhang G; Deng X; Rossi MR; Switchenko JM; Doho GH; Chen Z; Kim S; Strychor S; Christner SM
• Clinical and Pathologic Characterization of Folate Receptor Alpha, Mesothelin, and Endosialin Expression in Mesotheliomas
  Volume: 90 Page(s): S29 - S29
  11/15/2014 Authors: Owonikoko TK; Busari A; Chen Z; Kim S; Alexis D; Somers EB; O'Shannessy DJ; Ramalingam S; Khuri F; Sica GL
• Investigating the Molecular Profile of Lung Adenocarcinoma: A Single-Institution Analysis
  Volume: 90 Page(s): S50 - S51
  11/15/2014 Authors: Steuer C; Behera M; Rossi M; Fisher K; Sica G; Gal A; Pakkala S; Pillai R; Owonikoko T; Khuri F
• Integrated genomic characterization of papillary thyroid carcinoma.
  Cell Volume: 159 Page(s): 676 - 690
  10/23/2014 Authors: Cancer Genome Atlas Research Network
• Evaluating markers of cisplatin sensitivity and survival in small cell lung cancer
  Volume: 74
  10/01/2014 Authors: Owonikoko TK; Zhang G; Sica GL; Chen Z; Switchenko JM; Kim S; Gal AA; Ramalingam SS; Deng X; Rossi MR
• Preserved histological and molecular phenotypes following serial in vivo propagation of patient-derived xenografts of small cell lung cancer
  Volume: 74
  10/01/2014 Authors: Owonikoko TK; Zhang G; Sica GL; Kim HS; Ogee-Nwankwo OC; Ramalingam SS; Rossi MR; Khuri FR
• Development of small molecule Bax agonists for lung cancer treatment
  Volume: 74
  10/01/2014 Authors: Xin M; Li R; Park D; Owonikoko TK; Sica GL; Corsino PE; Ding JZC; Magis AT; Ramalingam SS; Curran WJ
• Small-molecule Bax agonists for cancer therapy.
  Nat Commun Volume: 5 Page(s): 4935
  09/17/2014 Authors: Xin M; Li R; Xie M; Park D; Owonikoko TK; Sica GL; Corsino PE; Zhou J; Ding C; White MA
• Comprehensive molecular profiling of lung adenocarcinoma (vol 489, pg 519, 2012)
  NATURE Volume: 513 Page(s): 543 - 550
  09/11/2014 Authors: Collisson EA; Campbell JD; Brooks AN; Berger AH; Lee W; Chmielecki J; Beers DG; Cope L; Creighton CJ; Danilova L
• Comprehensive molecular profiling of lung adenocarcinoma.
  Nature Volume: 511 Page(s): 543 - 550
  07/31/2014 Authors: Cancer Genome Atlas Research Network
• Expression of tumor biomarkers in HIV-infected patients with head and neck cancer.
  Volume: 32
  05/20/2014 Authors: Zhang H; Kim S; Chen Z; Nannapaneni S; Sica G; Carey TE; William WN; Minh LN; Riddell J; Pal SI
• The role of CHFR as a predictive marker of response to taxane-based preoperative chemotherapy in triple-negative breast cancer
  Volume: 32
  05/20/2014 Authors: Paplomata E; Sica G; Ehdaivand S; Nickleach D; Liu Y; Zelnak AB; O'Regan R; Brandes JC
• Chemoprevention of head and neck cancer with celecoxib and erlotinib: results of a phase ib and pharmacokinetic study.
  Cancer Prev Res (Phila) Volume: 7 Page(s): 283 - 291
  03/01/2014 Authors: Saba NF; Hurwitz SJ; Kono SA; Yang CS; Zhao Y; Chen Z; Sica G; Mller S; Moreno-Williams R; Lewis M
• Class I HDACs are mediators of smoke carcinogen-induced stabilization of DNMT1 and serve as promising targets for chemoprevention of lung cancer.
  Cancer Prev Res (Phila) Volume: 7 Page(s): 351 - 361
  03/01/2014 Authors: Brodie SA; Li G; El-Kommos A; Kang H; Ramalingam SS; Behera M; Gandhi K; Kowalski J; Sica GL; Khuri FR
• Disruption of STAT3 by niclosamide reverses radioresistance of human lung cancer.
  Mol Cancer Ther Volume: 13 Page(s): 606 - 616
  03/01/2014 Authors: You S; Li R; Park D; Xie M; Sica GL; Cao Y; Xiao Z-Q; Deng X
• Molecular Detection of Clinically Actionable Lung Cancer Mutations: Multiplexed Single Gene Assays Versus Next-Generation Sequencing Following Target-Enrichment
  Volume: 94 Page(s): 476A - 477A
  02/01/2014 Authors: Fisher KE; Wang J; Pillai RN; Owonikoko TK; Ramalingam SR; Khuri FR; Gal AA; Mann KP; Hill CE; Sica GL
• SOX2 Expression in EGFR and KRAS Mutated Lung Adenocarcinomas
  Volume: 27 Page(s): 476A - 476A
  02/01/2014 Authors: Fatima N; Fisher K; Rossi MR; Zhang L; Owanikoko T; Ramalingam S; Khuri F; Gal A; Cohen C; Sica G
• c-Met Immunohistochemistry in EGFR Mutant Adenocarcinoma: Comparison with Fluorescence In-Situ Hybridization
  Volume: 27 Page(s): 499A - 499A
  02/01/2014 Authors: Willis BC; Martin DR; Saxe D; Ramalingam SS; Khuri F; Fisher KE; Rossi MR; Cohen C; Sica G
• c-Met Immunohistochemistry in EGFR Mutant Adenocarcinoma: Comparison with Fluorescence In-Situ Hybridization
  Volume: 94 Page(s): 499A - 499A
  02/01/2014 Authors: Willis BC; Mortin DR; Saxe D; Ramalingam SS; Khuri F; Fisher KE; Rossi MR; Cohen C; Sica G
• SOX2 Expression in EGFR and KRAS Mutated Lung Adenocarcinomas
  Volume: 94 Page(s): 476A - 476A
  02/01/2014 Authors: Fatima N; Fisher K; Rossi MR; Zhang L; Owanikoko T; Ramalingam S; Khuri F; Gal A; Cohen C; Sica G
• Molecular Detection of Clinically Actionable Lung Cancer Mutations: Multiplexed Single Gene Assays Versus Next-Generation Sequencing Following Target-Enrichment
  Volume: 27 Page(s): 476A - 477A
  02/01/2014 Authors: Fisher KE; Wang J; Pillai RN; Owonikoko TK; Ramalingam SR; Khuri FR; Gal AA; Mann KP; Hill CE; Sica GL
• Synthetic curcumin analog UBS109 inhibits the growth of head and neck squamous cell carcinoma xenografts.
  Curr Cancer Drug Targets Volume: 14 Page(s): 380 - 393
  01/01/2014 Authors: Zhu S; Moore TW; Morii N; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ; Zhang H; Sica G
• A PHASE IB PREOPERATIVE PHARMACOKINETIC AND PHARMACODYNAMIC STUDY OF EVEROLIMUS IN OPERABLE NON SMALL CELL LUNG CANCER
  JOURNAL OF THORACIC ONCOLOGY Volume: 8 Page(s): S628 - S629
  11/01/2013 Authors: Owonikoko TK; Miller DL; Force S; Sica G; Saba NF; Kono SA; Behera M; Lewis C; Chen Z; Pickens A
• A 22-year-old woman with bronchiectasis and a mediastinal mass.
  Chest Volume: 144 Page(s): 1406 - 1409
  10/01/2013 Authors: Hunt WR; Allam JS; Sica G; Little BP; Veeraraghavan S
• Niclosamide overcomes acquired resistance to erlotinib through suppression of STAT3 in non-small cell lung cancer.
  Mol Cancer Ther Volume: 12 Page(s): 2200 - 2212
  10/01/2013 Authors: Li R; Hu Z; Sun S-Y; Chen ZG; Owonikoko TK; Sica GL; Ramalingam SS; Curran WJ; Khuri FR; Deng X
• Recurrence of pulmonary carcinoid tumors after resection: implications for postoperative surveillance.
  Ann Thorac Surg Volume: 96 Page(s): 1156 - 1162
  10/01/2013 Authors: Lou F; Sarkaria I; Pietanza C; Travis W; Roh MS; Sica G; Healy D; Rusch V; Huang J
• Novel small-molecule inhibitors of Bcl-XL to treat lung cancer.
  Cancer Res Volume: 73 Page(s): 5485 - 5496
  09/01/2013 Authors: Park D; Magis AT; Li R; Owonikoko TK; Sica GL; Sun S-Y; Ramalingam SS; Khuri FR; Curran WJ; Deng X
• Primary pericardial mesothelioma in a 19-year-old presenting as pericarditis.
  Ann Thorac Surg Volume: 96 Page(s): 680 - 681
  08/01/2013 Authors: Kayatta MO; Dineen SP; Sica G; Puskas JD; Pickens A
• RRM2 regulates Bcl-2 in head and neck and lung cancers: a potential target for cancer therapy.
  Clin Cancer Res Volume: 19 Page(s): 3416 - 3428
  07/01/2013 Authors: Rahman MA; Amin ARMR; Wang D; Koenig L; Nannapaneni S; Chen Z; Wang Z; Sica G; Deng X; Chen ZG
• Interruption of nuclear localization of ATBF1 during the histopathologic progression of head and neck squamous cell carcinoma.
  Head Neck Volume: 35 Page(s): 1007 - 1014
  07/01/2013 Authors: Sun X; Li J; Sica G; Fan S-Q; Wang Y; Chen Z; Muller S; Chen ZG; Fu X; Dong X-Y
• Multiplatform assessment of anaplastic lymphoma kinase (ALK) gene rearrangement in signet ring cell carcinoma of the gastrointestinal tract
  Volume: 31
  05/20/2013 Authors: Alese OB; El-Rayes BF; Sica G; Zhang G; Rossi MR; Adsay V; Alexis D; La Rosa FG; Varella-Garcia M; Chen Z
• Development of small molecule BcI-XL inhibitors for treatment of lung cancer
  Volume: 73
  04/15/2013 Authors: Park D; Magis AT; Li R; Owonikoko TKK; Sica GL; Sun S-Y; Ramalingam SS; Khuri FR; Curran WJ; Deng X
• Window of opportunity preoperative interrogation of mTOR pathway in patients with resectable non-small cell lung cancer (NSCLC).
  Volume: 73
  04/15/2013 Authors: Owonikoko TK; Miller DL; Force S; Sica G; Kono S; Behera M; Mendel J; Chen Z; Pickens A; Fu RW
• CHFR protein expression predicts outcomes to taxane-based first line therapy in metastatic NSCLC.
  Clin Cancer Res Volume: 19 Page(s): 1603 - 1611
  03/15/2013 Authors: Pillai RN; Brodie SA; Sica GL; Shaojin Y; Li G; Nickleach DC; Yuan L; Varma VA; Bonta D; Herman JG
• Phase II study of docetaxel in combination with everolimus for second- or third-line therapy of advanced non-small-cell lung cancer.
  J Thorac Oncol Volume: 8 Page(s): 369 - 372
  03/01/2013 Authors: Ramalingam SS; Owonikoko TK; Behera M; Subramanian J; Saba NF; Kono SA; Gal AA; Sica G; Harvey RD; Chen Z
• Survival analysis of patients with stage I non-small-cell lung cancer using clinical and DNA repair pathway expression variables.
  Clin Lung Cancer Volume: 14 Page(s): 128 - 138
  03/01/2013 Authors: Behera M; Heine JJ; Sica GL; Fowler EE; Tran H; Fu RW; Gal AA; Hermann R; Mayfield W; Khuri FR
• Chemoprevention of head and neck cancer by simultaneous blocking of epidermal growth factor receptor and cyclooxygenase-2 signaling pathways: preclinical and clinical studies.
  Clin Cancer Res Volume: 19 Page(s): 1244 - 1256
  03/01/2013 Authors: Shin DM; Zhang H; Saba NF; Chen AY; Nannapaneni S; Amin ARMR; Mller S; Lewis M; Sica G; Kono S
• Effect of the Duration of Cold Ischemic Time and Temperature Conditions on Maintenance of RNA Integrity Number (RIN) in Biospecimens
  Volume: 26 Page(s): 485A - 485A
  02/01/2013 Authors: Sica G; Butler C; Zhang G; Maithel S; Rossi M; Owonikoko T
• Effect of the Duration of Cold Ischemic Time and Temperature Conditions on Maintenance of RNA Integrity Number (RIN) in Biospecimens
  Volume: 93 Page(s): 485A - 485A
  02/01/2013 Authors: Sica G; Butler C; Zhang G; Maithel S; Rossi M; Owonikoko T
• WHO Histologic Classification Is an Independent Predictor of Prognosis in Lung Neuroendocrine (NE) Tumors but Ki-67 Proliferation Rate Is Not
  Volume: 26 Page(s): 469A - 469A
  02/01/2013 Authors: Wang H; Iyoda A; Roh MS; Sica G; Rekhtman N; Pietanza MC; Sarkaria I; Travis WD
• Epithelioid PEComa (epithelioid angiomyolipoma) of the kidney: a rare tumor subtype for patients presenting with an enhancing renal mass.
  Can J Urol Volume: 20 Page(s): 6643 - 6645
  02/01/2013 Authors: Shrewsberry AB; Sica GL; Osunkoya AO; Canter DJ
• WHO Histologic Classification Is an Independent Predictor of Prognosis in Lung Neuroendocrine (NE) Tumors but Ki-67 Proliferation Rate Is Not
  Volume: 93 Page(s): 469A - 469A
  02/01/2013 Authors: Wang H; Iyoda A; Roh MS; Sica G; Rekhtman N; Pietanza MC; Sarkaria I; Travis WD
• Inhibition of STAT3 by niclosamide synergizes with erlotinib against head and neck cancer.
  PLoS One Volume: 8 Page(s): e74670
  01/01/2013 Authors: Li R; You S; Hu Z; Chen ZG; Sica GL; Khuri FR; Curran WJ; Shin DM; Deng X
• Unusual suspects: pulmonary opportunistic infections masquerading as tumor metastasis in a patient with adrenocorticotropic hormone-producing pancreatic neuroendocrine cancer.
  Ther Adv Med Oncol Volume: 4 Page(s): 295 - 300
  11/01/2012 Authors: Chowdry RP; Bhimani C; Delgado MA; Lee DJ; Dayamani P; Sica GL; Owonikoko TK
• Tissue Expression of Activated Phosphorylated Forms of Bcl2 and Mcl1 as Prognostic Markers in Small Cell Lung Cancer
  JOURNAL OF THORACIC ONCOLOGY Volume: 7 Page(s): S219 - S219
  09/01/2012 Authors: Owonikoko TK; Chowdry RP; Chen Z; Goodman A; Kim S; Deng X; Gal A; Khuri FR; Ramalingam SS; Sica G
• Lung cancer staging: pathology issues.
  Semin Diagn Pathol Volume: 29 Page(s): 116 - 126
  08/01/2012 Authors: Sica GL; Gal AA
• Synthetic curcumin analog EF31 inhibits the growth of head and neck squamous cell carcinoma xenografts.
  Integr Biol (Camb) Volume: 4 Page(s): 633 - 640
  06/01/2012 Authors: Zhu S; Moore TW; Lin X; Morii N; Mancini A; Howard RB; Culver D; Arrendale RF; Reddy P; Evers TJ
• Expression pattern and biologic relevance of Bcl-2 and Mcl-1 in pulmonary neuroendocrine tumors.
  Volume: 30
  05/20/2012 Authors: Chowdry RP; Sica G; Chen Z; Goodman A; Kim S; Deng X; Curran WJ; Gal AA; Khuri FR; Ramalingam SS
• Cytological cell blocks: Predictors of squamous cell carcinoma and adenocarcinoma subtypes.
  Diagn Cytopathol Volume: 40 Page(s): 380 - 387
  05/01/2012 Authors: Loukeris K; Vazquez MF; Sica G; Wagner P; Yankelevitz DF; Henschke CI; Cham MD; Saqi A
• An endogenous mTOR inhibitor, PRAS40, is upregulated in lung cancer and contributes to tumor cell invasion and chemoresistance
  CANCER RESEARCH Volume: 72
  04/15/2012 Authors: Li Z; Du Y; Sica G; Ramalingam SS; Gal AA; Pan L; Tighiouart MM; Khuri FRFR; Fu H
• Gene Expression Profiling of Lung Neuroendocrine (NE) Tumors Reveals Gene Clusters Correlated with Central Versus Peripheral Location for Carcinoids
  Volume: 25 Page(s): 492A - 492A
  02/01/2012 Authors: Wang H; Roh MS; Shen R; Zheng J; Sica G; Stock C; Sarkaria I; Pietanza M; Rekhtman N; Iyoda A
• Gene Expression Profiling of Lung Neuroendocrine (NE) Tumors Reveals Gene Clusters Correlated with Central Versus Peripheral Location for Carcinoids
  Volume: 92 Page(s): 492A - 492A
  02/01/2012 Authors: Wang H; Roh MS; Shen R; Zheng J; Sica G; Stock C; Sarkaria I; Pietanza M; Rekhiman N; Iyoda A
• Rapamycin induces Bad phosphorylation in association with its resistance to human lung cancer cells.
  Mol Cancer Ther Volume: 11 Page(s): 45 - 56
  01/01/2012 Authors: Liu Y; Sun S-Y; Owonikoko TK; Sica GL; Curran WJ; Khuri FR; Deng X
• Metabolomic profiling reveals potential markers and bioprocesses altered in bladder cancer progression.
  Cancer Res Volume: 71 Page(s): 7376 - 7386
  12/15/2011 Authors: Putluri N; Shojaie A; Vasu VT; Vareed SK; Nalluri S; Putluri V; Thangjam GS; Panzitt K; Tallman CT; Butler C
• Neoadjuvant and adjuvant chemotherapy in resected pulmonary large cell neuroendocrine carcinomas: a single institution experience.
  Ann Thorac Surg Volume: 92 Page(s): 1180 - 1186
  10/01/2011 Authors: Sarkaria IS; Iyoda A; Roh MS; Sica G; Kuk D; Sima CS; Pietanza MC; Park BJ; Travis WD; Rusch VW
• A PHASE IB WINDOW OF OPPORTUNITY CLINICAL STUDY WITH EVEROLIMUS IN PATIENTS WITH RESECTABLE NON-SMALL CELL LUNG CANCER (NSCLC)
  JOURNAL OF THORACIC ONCOLOGY Volume: 6 Page(s): S967 - S968
  06/01/2011 Authors: Owonikoko TK; Force S; Sica G; Bechara R; Harvey RD; Sun S-Y; Saba N; Rogerio J; Gal A; Kono S
• ANALYSIS OF MTOR SIGNALING PATHWAY BIOMARKERS IN NON-SMALL CELL LUNG CANCER PATIENTS TREATED WITH EVEROLIMUS AND DOCETAXEL IN A PHASE II CLINICAL TRIAL.
  JOURNAL OF THORACIC ONCOLOGY Volume: 6 Page(s): S1039 - S1040
  06/01/2011 Authors: Owonikoko TK; Ramalingam S; Subramanian J; Sica G; Chen Z; Behera M; Rogerio J; Saba N; Tighiouart M; Gal A
• Everolimus, an mTOR inhibitor, in combination with docetaxel for second- or third-line therapy of advanced-stage non-small cell lung cancer: A phase II study.
  J Clin Oncol Volume: 29 Page(s): e13601
  05/20/2011 Authors: Khuri FR; Owonikoko TK; Subramanian J; Sica G; Behera M; Saba NF; Chen Z; Tighiouart M; Shin DM; Sun S
• Mislocalization of ATBF1 is associated with progression of head and neck squamous cell carcinoma
  CANCER RESEARCH Volume: 71
  04/15/2011 Authors: Sun X; Li J; Sica G; Fan S-Q; Wang Y; Chen Z; Muller S; Chen ZG; Shin DM; Dong J-T
• The Utility of SOX-2 as a Marker of Squamous Differentiation in Fine Needle Aspiration Biopsy Material of the Lung
  Volume: 24 Page(s): 85A - 85A
  02/01/2011 Authors: Caltharp SA; Siddiqui MT; Cohen C; Hanley K; Sica GL
• Radiation Induces Upregulation of GRP94 (GP96) in Human Head and Neck Tumors
  INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS Volume: 81 Page(s): S483 - S483
  01/01/2011 Authors: Corso C; Wen J; Sica G; Muller S; Han JM; Kim S; Diaz R
• A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.
  Am J Surg Pathol Volume: 34 Page(s): 1155 - 1162
  08/01/2010 Authors: Sica G; Yoshizawa A; Sima CS; Azzoli CG; Downey RJ; Rusch VW; Travis WD; Moreira AL
• Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic Analysis of 23 Cases
  Volume: 90 Page(s): 168A - 168A
  02/01/2010 Authors: Sica G; Dursun N; Roa JC; Tapia O; Cakir A; Coban I; Sarmiento J; Basturk O; Ohike N; Cheng J
• Neuroendocrine Carcinomas of the Gallbladder: A Clinicopathologic Analysis of 23 Cases
  Volume: 23 Page(s): 168A - 168A
  02/01/2010 Authors: Sica G; Dursun N; Roa JC; Tapia O; Cakir A; Coban I; Sarmiento J; Basturk O; Ohike N; Cheng J
• Radiation Induces Upregulation of GRP78 in Human Head and Neck Tumors
  Volume: 78 Page(s): S623 - S623
  01/01/2010 Authors: Ali AN; Lopez-Barcons LA; Feingold PL; Sica G; Willard M; Muller S; Diaz R
• p53 overexpression in morphologically ambiguous endometrial carcinomas correlates with adverse clinical outcomes.
  Mod Pathol Volume: 23 Page(s): 80 - 92
  01/01/2010 Authors: Garg K; Leitao MM; Wynveen CA; Sica GL; Shia J; Shi W; Soslow RA
• A grading system of lung adenocarcinomas (AD) is predictive of earlier disease recurrence in stage 1 adenocarcinoma
  JOURNAL OF THORACIC ONCOLOGY Volume: 4 Page(s): S498 - S498
  09/01/2009 Authors: Sica G; Downey R; Rusch V; Travis WD; Moreira AL
• Tumor microenvironment of metastasis in human breast carcinoma: a potential prognostic marker linked to hematogenous dissemination.
  Clin Cancer Res Volume: 15 Page(s): 2433 - 2441
  04/01/2009 Authors: Robinson BD; Sica GL; Liu Y-F; Rohan TE; Gertler FB; Condeelis JS; Jones JG
• CXCL12 and CXCR4 in adenocarcinoma of the lung: association with metastasis and survival.
  J Thorac Cardiovasc Surg Volume: 137 Page(s): 615 - 621
  03/01/2009 Authors: Wagner PL; Hyjek E; Vazquez MF; Meherally D; Liu YF; Chadwick PA; Rengifo T; Sica GL; Port JL; Lee PC
• Strong Correlation between Solid and Micropapillary Subtypes of Lung Adenocarcinoma (AD) in Primary and Metastatic Sites
  Volume: 89 Page(s): 361A - 362A
  01/01/2009 Authors: Sica G; Travis W; Moreira A
• Strong Correlation between Solid and Micropapillary Subtypes of Lung Adenocarcinoma (AD) in Primary and Metastatic Sites
  Volume: 22 Page(s): 361A - 362A
  01/01/2009 Authors: Sica G; Travis W; Moreira A
• COP, GOP and AFOP in a Cancer Hospital.
  AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE Volume: 179
  01/01/2009 Authors: DeSouza SA; Sica G; Feinstein M; Moreira AL; Travis W; Stover D
• Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors.
  Arch Pathol Lab Med Volume: 132 Page(s): 1889 - 1895
  12/01/2008 Authors: Sica G; Wagner PL; Altorki N; Port J; Lee PC; Vazquez MF; Saqi A
• PAX-5 expression in pulmonary neuroendocrine neoplasms: its usefulness in surgical and fine-needle aspiration biopsy specimens.
  Am J Clin Pathol Volume: 129 Page(s): 556 - 562
  04/01/2008 Authors: Sica G; Vazquez MF; Altorki N; Port J; Lee PC; Liu Y; Hyjek E; Saqi A
• Reassessment of the histologic spectrum of mucinous bronchioloalveolar carcinomas (mBAC)
  Volume: 88 Page(s): 351A - 351A
  01/01/2008 Authors: Sica G; Yoshizawa A; Klimstra D; Gerald W; Travis W
• Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors
  Volume: 87 Page(s): 331A - 331A
  03/01/2007 Authors: Sica GL; Vasquez MF; Hyjek E; Liu Y-F; Saqi A
• Immunohistochemical expression of estrogen and progesterone receptors in primary pulmonary neuroendocrine tumors
  Volume: 20 Page(s): 331A - 331A
  03/01/2007 Authors: Sica GL; Vazquez MF; Hyjek E; Liu Y-F; Saqi A
• CXCR4 expression in stage I, stage II and multifocal non-small cell lung carcinomas
  Volume: 20 Page(s): 333A - 333A
  03/01/2007 Authors: Wagner P; Vazquez M; Sica G; Hyjek E; Liu YF; Altorki N; Saqi A
• KRAS, EGFR and p53 alterations in bronchioloalveolar carcinoma and BAC-predominant adenocarcinoma
  Volume: 87 Page(s): 331A - 331A
  03/01/2007 Authors: Sica G; Saqi A; Kitabayashi N; Altorki N; Vazquez MF; Chen YT
• Combined cytopathologic and radiologic diagnosis of adenocarcinoma with bronchioloalveolar alveolar features (ADC-BAC) is highly predictive of subsequent histopathologic diagnosis and clinical outcome
  Volume: 20 Page(s): 317A - 317A
  03/01/2007 Authors: Aslan DL; Wagner P; Sica G; Horshan M; Crapanzano JP; Saqi A; Vazquez MF
• CXCR4 expression in stage I, stage II and multifocal non-small cell lung carcinomas
  Volume: 87 Page(s): 333A - 333A
  03/01/2007 Authors: Wagner P; Vasquez M; Sica G; Hyjek E; Liu YF; Altorki N; Saqi A
• Evaluation of the tumor microenvironment for metastasis (TMEM) and its associated invasion signature in human breast carcinoma
  Volume: 87 Page(s): 308A - 308A
  03/01/2007 Authors: Jones J; Sica G; Liu Y-F; Wang W; Sahai E; Mottolese M; Nistico P; Philippar U; Gertler F; Condeelis J
• KRAS, EGFR and p53 alterations in bronchioloalveolar carcinoma and BAC-predominant adenocarcinoma
  Volume: 20 Page(s): 331A - 331A
  03/01/2007 Authors: Sica G; Saqi A; Kitabayashi N; Altorki N; Vazquez MF; Chen YT
• Mutational analysis supports independent de novo carcinogenesis in multifocal adenocarcinoma of the lung with bronchioloalveolar features
  Volume: 87 Page(s): 331A - 331A
  03/01/2007 Authors: Sica G; Saqi A; Kitabayashi A; Altorki N; Vazquez MF; Chen YT
• Evaluation of the tumor microenvironment for metastasis (TMEM) and its associated invasion signature in human breast carcinoma
  Volume: 20 Page(s): 308A - 308A
  03/01/2007 Authors: Jones J; Sica G; Liu Y-F; Wang W; Sahai E; Mottolese M; Nistico P; Philippar U; Gertler F; Condeelis J
• Combined cytopathologic and radiologic diagnosis of adenocarcinoma with bronchioloalveolar alveolar features (ADC-BAC) is highly predictive of subsequent histopathologic diagnosis and clinical outcome
  Volume: 87 Page(s): 317A - 317A
  03/01/2007 Authors: Aslan DL; Wagner P; Sica G; Harshan M; Crapanzano JP; Saqi A; Vazquez MF
• Mutational analysis supports independent de novo carcinogenesis in multifocal adenocarcinoma of the lung with bronchioloalveolar features
  Volume: 20 Page(s): 331A - 331A
  03/01/2007 Authors: Sica G; Saqi A; Kitabayashi N; Atorki N; Vazquez MF; Chen YT
• Utility of pax-5 expression in fine needle aspiration biopsies for differentiating pulmonary neuroendocrine neoplasms
  Volume: 19 Page(s): 38 - 38
  09/01/2006 Authors: Sica G; Zhang W; Vazquez MF; Saqi A
• CD44V6 is a marker of metastatic potential in breast cancer
  Volume: 19 Page(s): 27 - 27
  09/01/2006 Authors: Zhang W; Hyjek E; Sica G; Hoda S
• Genomic organization and expression analysis of B7-H4, an immune inhibitory molecule of the B7 family.
  J Immunol Volume: 171 Page(s): 4650 - 4654
  11/01/2003 Authors: Choi I-H; Zhu G; Sica GL; Strome SE; Cheville JC; Lau JS; Zhu Y; Flies DB; Tamada K; Chen L
• B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
  Immunity Volume: 18 Page(s): 849 - 861
  06/01/2003 Authors: Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
• Adherence of published diabetes mellitus practice guidelines to methodologic standards of guideline development.
  Endocrinol Metab Clin North Am Volume: 31 Page(s): 819 - 828
  09/01/2002 Authors: Sica G; Harker-Murray P; Montori VM; Smith SA; EVIDENS Groups
• RELT, a new member of the tumor necrosis factor receptor superfamily, is selectively expressed in hematopoietic tissues and activates transcription factor NF-kappaB.
  Blood Volume: 97 Page(s): 2702 - 2707
  05/01/2001 Authors: Sica GL; Zhu G; Tamada K; Liu D; Ni J; Chen L
• B7-H1 costimulation preferentially enhances CD28-independent T-helper cell function.
  Blood Volume: 97 Page(s): 1809 - 1816
  03/15/2001 Authors: Tamura H; Dong H; Zhu G; Sica GL; Flies DB; Tamada K; Chen L
• B7-H3, a novel member of the B7 family that costimulates T cell responses and selectively enhances interferon-gamma production
  FASEB JOURNAL Volume: 15 Page(s): A345 - A345
  03/07/2001 Authors: Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong HD; Sica GL; Zhu GF; Tamada K
• TNFRSF19L, a new member of tumor necrosis factor receptor superfamily, that is expressed in lymphoid organs and activates NF-kappa B
  FASEB JOURNAL Volume: 15 Page(s): A700 - A700
  03/07/2001 Authors: Sica G; Zhu GF; Tamada K; Liu D; Ni J; Chen LP
• B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production.
  Nat Immunol Volume: 2 Page(s): 269 - 274
  03/01/2001 Authors: Chapoval AI; Ni J; Lau JS; Wilcox RA; Flies DB; Liu D; Dong H; Sica GL; Zhu G; Tamada K
• 4-1BB ligation following peptide immunization amplifies an anti-tumor CTL response
  FASEB JOURNAL Volume: 14 Page(s): A1004 - A1004
  04/20/2000 Authors: Wilcox RA; Tamada K; Chapoval AI; Sica G; Flies D; Johnson A; Pease LR; Chen L
• Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway.
  Nat Med Volume: 6 Page(s): 283 - 289
  03/01/2000 Authors: Tamada K; Shimozaki K; Chapoval AI; Zhu G; Sica G; Flies D; Boone T; Hsu H; Fu YX; Nagata S
• Modulation of the immune response through 4-1BB.
  Adv Exp Med Biol Volume: 465 Page(s): 355 - 362
  01/01/2000 Authors: Sica G; Chen L
• Biochemical and immunological characteristics of 4-1BB (CD137) receptor and ligand and potential applications in cancer therapy.
  Arch Immunol Ther Exp (Warsz) Volume: 47 Page(s): 275 - 279
  01/01/1999 Authors: Sica G; Chen L